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 2 
Abstract 
 
The P2X4 receptor is involved in endothelium-dependent changes in large arterial tone in 
response to shear stress and is, therefore, potentially relevant to arterial compliance and pulse 
pressure. Four identified non-synonymous polymorphisms in P2RX4 were reproduced in 
recombinantly-expressed human P2X4. Electrophysiological studies showed that one of these, 
the Tyr315>Cys mutation (rs28360472), significantly reduced the peak amplitude of the ATP-
induced inward current to 10.9% of wild-type P2X4 receptors in transfected HEK-293 cells (10 
µmol/L ATP, n = 4-8 cells, P<0.001). Concentration-response curves for ATP and the partial 
agonist BzATP demonstrate that the 315Cys-P2X4 mutant had an increased EC50 value for both 
ligands. Mutation of Tyr315>Cys likely disrupts the agonist binding site of P2X4 receptors, a 
finding supported by molecular modelling based on the zebrafish P2X4 receptor crystal 
structure. We tested inheritance of rs28360472 encoding the Tyr315>Cys mutation in P2RX4 
against pulse pressure in 2874 subjects from the Victorian Family Heart Study. The minor allele 
frequency was 0.014 (1.4%). In a variance components analysis we found significant association 
with pulse pressure (P = 0.023 for total association) where one minor allele increased pulse 
pressure by 2.84 mmHg (95% CI 0.41 to 5.27). This increase in pulse pressure associated with 
inheritance of 315Cys-P2X4 receptors might reflect reduced large arterial compliance as a result 
of impaired endothelium-dependent vasodilation in large arteries. 
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 3 
Introduction 
 
Pulse pressure is recognised as an independent risk factor for cardiovascular disease 1 and is 
determined by large artery compliance as well as by cardiac stroke volume and reflected 
pressure waves. Endothelial cell responses to blood flow have an important role in the control of 
vascular tone and it is well documented that endothelial cells release ATP in response to shear 
stress produced by the flow of blood 2. ATP is the physiological ligand for the purinergic 
receptor family comprising seven ligand-gated ion channels (P2X1-P2X7) and seven 
metabotropic P2Y receptors (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y14) 3. P2X4 
receptors are expressed in vascular endothelial cells where this receptor functions in shear 
stress-induced calcium signalling and the generation of nitric oxide (NO) 4-6. P2X4 receptors 
show fast activation kinetics with high permeability to Ca2+ ions 7 and is the only P2X receptor 
to show potentiation by the pharmacological agent ivermectin 8.  Anti-sense knockdown of 
P2X4 receptors abolishes shear stress-induced Ca2+ signals in endothelial cells 9 and the P2X4 
receptor knockout mouse exhibits reduced shear stress-mediated Ca2+ influx into cultured 
endothelial cells and reduced production of NO 10. Endothelial responses to shear stress are 
important in regulating the compliance of large arteries, an intrinsic property of the vessel wall 
with effects particularly on pulse pressure. Thus it could be hypothesized that functional 
variations in the human P2X4 receptor may play an important role in shear stress related 
parameters within the vasculature.   
The human P2X4 receptor gene (P2RX4) is located on chromosome 12q24.32 11 and 
contains a number of non-synonymous single nucleotide polymorphisms (SNPs). Here we 
determined functional effects of four non-synonymous coding SNPs in P2RX4 and focussed our 
investigation on one SNP (rs28360472) that leads to loss of P2X4 receptor function through 
disruption of the agonist binding site and is associated with increased pulse pressure.  
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Methods 
Detailed methods are available in the online supplement (please see 
http://hyper.ahajournals.org). 
 
For the Sydney cohort, genomic DNA was prepared from peripheral venous blood as described 
previously 12 and the study was approved by Sydney West Area Health Service HREC Nepean 
with informed written consent obtained from all participants. Four non-synonymous SNPs in 
P2RX4 were genotyped in the Sydney cohort to determine minor allele frequencies; rs1044249, 
rs28360470, rs25644, and rs28360472. For the Victorian cohort, the details of the recruitment of 
participants for the Victorian Family Heart Study (VFHS) have been published previously 13, 14 
and the study was approved by the Ethics Review Committee of the Alfred Hospital, Melbourne 
with informed consent obtained from all participants.  Blood pressure measurements on 
participants of the VFHS were taken carefully using a calibrated mercury sphygmomanometer 
by trained observers. Pulse pressure was calculated as the difference between systolic and 
diastolic pressure.  
HEK-293 cells were transfected with wild-type or mutated EGFP-tagged human P2X4 receptor 
and functional responses measured by whole cell patch clamping15. Surface staining was 
performed on transfected HEK-293 cells using a rabbit anti-human P2X4 antibody.  
Peripheral venous blood was taken from healthy volunteers carrying no mutations in P2RX4 
(wild-type) or carrying one allele of rs28360472. CD14+ monocytes were isolated and 
differentiated to macrophages. For functional experiments, data are presented as mean ± S.E.M. 
Statistical analysis was performed using t-tests or ANOVA where appropriate with Instat 
version 3 (GraphPad Software Inc.). 
A molecular model of the human P2X4 receptor was built by homology to the zebra-fish P2X4 
receptor structure (pdb code 3I5D 16) using SwissModel 17 to explore the putative ATP-binding 
pocket in wild-type P2X4 and 315Cys-P2X4 receptors.  
 5 
For the VFHS cohort statistical association between genotype and pulse pressure was assessed 
using variance components modelling and the quantitative trait linkage disequilibrium (QTLD) 
approach.  
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Results 
Polymorphic variants of the P2X4 Receptor  
Four non-synonymous coding SNPs in the P2RX4 gene were identified in NCBI dbSNP 
database (using build 126). The mutations were introduced into a human P2X4 receptor plasmid 
and expressed in HEK-293 cells to ascertain whether these mutations altered functional 
responses. We measured ATP-induced inward currents by whole cell patch clamp (Figure 1A) 
and found only the Tyr315>Cys mutation (rs28360472) to have a significant effect, reducing the 
amplitude of the P2X4 response to 10.9% of wild-type P2X4 receptors (n=4-8 cells, P<0.001). 
The mutations altering Ala6>Ser (rs1044249), Ile119>Val (rs28360470) and Ser242>Gly 
(rs25644) had no major effect (n=4-8 cells, Figure 1). As expected all P2X4 receptor constructs 
displayed potentiation by the allosteric modulator ivermectin (data not shown). We found the 
cell surface expression of 315Cys-P2X4 receptors was reduced compared to wild-type P2X4 
receptors where mean fluorescent intensity was 62.7% of wild-type P2X4 receptors (please see 
supplemental figure S1 http://hyper.ahajournals.org). The 315Cys-P2X4 mutant exhibited a 
right-shifted concentration-response curve and approximately 40-fold higher EC50 value relative 
to the wild-type P2X4 receptor (Table 1) whereas the other P2X4 mutations showed no 
significant difference (Table 1). Tyrosine 315 is thought to contribute to an agonist binding 
domain in the P2X4 receptor 18 therefore we used BzATP, a known partial agonist at P2X4 
receptors 19, which also showed a right-shifted concentration-response curve and an increased 
EC50 value in the 315Cys-P2X4 receptor compared to the wild-type P2X4 receptor (Figure 1C).  
 
The Tyr315>Cys polymorphism affects P2X4 receptor ectodomain structure   
P2X receptors have 10 conserved cysteine residues in the ectodomain, thought to stabilise the 
structure through five disulphide bonds 20, 21. The Tyr315>Cys mutation in the P2X4 receptor 
introduces an additional cysteine residue into the ectodomain which may destabilise the 
structure of the receptor and permit aberrant disulphide bonding contributing to the reduced 
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maximal response. We mutated the Tyr315 residue to serine, which cannot form disulphide 
bonds, and this 315Ser-P2X4 mutant showed a similar right-shifted ATP concentration-response 
curve and higher EC50 value (EC50 ATP = 243 µmol/L) compared to the wild-type P2X4 
receptor but did not show a reduced maximal response to ATP (Figure 2A, B). Cell surface 
expression of 315Ser-P2X4 receptors was similar to 315Cys-P2X4 receptors (please see 
supplemental figure S2 http://hyper.ahajournals.org).  Therefore we suggest there are two 
distinct effects with a mutation of Tyr315 to cysteine; mutation away from tyrosine affects 
agonist potency and the introduction of an extra cysteine residue reduces the maximum 
response. We investigated this further by using a short treatment of the reducing agent DTT to 
disrupt disulphide bonds and found this rescued the maximum response in 315Cys-P2X4 
receptors to a level similar to that of wild-type P2X4 and 315Ser-P2X4 receptors (Figure 2C, 
D). Similar DTT treatment did not affect peak current response to ATP for wild-type P2X4 
receptors (data not shown) and DTT had no effect on P2X4 receptor surface expression (please 
see supplemental figure S3 http://hyper.ahajournals.org).  
 
Inheritance of one copy of rs28360472 impairs P2X4 receptor responses 
We genotyped 200-430 normal Caucasian subjects from the greater Sydney area (Sydney 
cohort) at each of the four identified polymorphic positions. We found no subjects carrying the 
variant allele at rs1044249 or rs28360470 although these have been reported by others 22. 
rs25644 was found to have an allele frequency of 0.116 (n= 268 subjects) and the loss-of-
function SNP rs28360472 was found to have a frequency of 0.011 (n=430 subjects, Table 2).  
rs28360472 was found only in heterozygous dosage and therefore to determine whether 
inheritance of one allele encoding Tyr315>Cys would have a significant functional effect, we 
performed co-transfection experiments in HEK-293 cells to mimic a heterozygous state. Co-
expression reduced the ATP-induced inward current to 40% of wild-type P2X4 receptors alone 
(39.8 ± 9.6 pA/pF for WT/315Cys compared to 111.1 ± 11.2 pA/pF for WT P2X4 receptors 
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alone, n= 4-8 cells, P<0.01, Figure 3A,B). To determine if this reduction in P2X4 response was 
also seen in native cells, we recorded ATP-induced inward currents from monocyte-derived 
macrophages isolated from wild-type P2X4 and 315Cys-P2X4 heterozygous subjects. We found 
the mean current density for the P2X4 response in 315Cys heterozygote macrophages was 40% 
of the P2X4 response in wild-type macrophages (0.53 ± 0.19 pA/pF (n=13 cells, 315Cys 
heterozygotes) compared to 1.32 ± 0.13 pA/pF (n=15 cells, WT subjects), P<0.01, Figure 
3C,D).  
 
Inheritance of rs28360472 (Tyr315>Cys) is associated with increased pulse pressure  
A second cohort of 2874 subjects from the Victorian Family Heart Study 14 were genotyped for 
rs28360472 to determine if inheritance of this SNP was associated with pulse pressure. The 
variant allele was found to have an allele frequency of 0.014 in this cohort (Table 2) and was 
present in 89 heterozygotes and one homozygote. The variant allele was in Hardy-Weinberg 
equilibrium (P = 0.42) and there was no evidence of population stratification (P = 0.73). Using 
variance components models and the total association test we found that rs28360472 was 
associated with a slightly higher systolic and slightly lower diastolic blood pressure and was 
associated with a greater pulse pressure (P = 0.023). We estimated that one or more copies of 
the variant allele increased pulse pressure by 2.84 mmHg (95% CI 0.41 to 5.27, Table 
3). Almost identical results were obtained for the Quantitative Trait Linkage Disequilibrium test 
(P=0.025).  
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Discussion  
In this study we present evidence that an uncommon genetic variant, rs28360472, 
encoding amino acid change Tyr315>Cys, in the human P2X4 receptor gene reduces the 
receptor functional response and shows an association with increased pulse pressure in a large 
Caucasian cohort. These observations are consistent with the hypothesis that the loss-of-function 
variant depresses the normal endothelial vasodilatory mechanisms involving the P2X4 receptor 
and results in reduced large arterial compliance and an increase in pulse pressure.  
The Tyr315>Cys mutation has two distinct effects on the ATP-induced human P2X4 
receptor response. The first is a reduction in agonist potency as demonstrated by an increase in 
EC50 values for the primary agonist ATP and the partial agonist BzATP. This confirms that 
Tyr315 contributes to the agonist binding site on the P2X4 receptor, as shown by several 
mutagenesis studies on rat P2X receptors 18, 23, 24 and also by molecular modelling (Figure 4) 
based on the recently published crystal structure of the zebrafish P2X4 receptor 16. Our 
molecular modelling analysis of the human P2X4 receptor structure shows that Tyr315 
contributes to a putative ATP-binding pocket at the subunit interface lined by several other 
residues that have been implicated in ATP binding 16.  Computational docking of ATP at this 
pocket revealed that, relative to wild-type P2X4 receptors, docking to 315Cys-P2X4 receptors 
showed a different preferred pose that would clash with the Tyr315 side-chain in the wild-type 
P2X4 receptor (Figure 4). Furthermore no cluster of poses were observed when docking to the 
315Cys-P2X4 receptor that were similar to the preferred docking pose for the wild-type P2X4 
receptor. Similar results were observed with Tyr315>Ser and Tyr315>Ala models of the P2X4 
receptor (data not shown) consistent with the hypothesis that Tyr315 makes a direct contribution 
to the ATP-binding site that is lost with mutation to cysteine, serine or alanine.  
The second effect of the Tyr315>Cys mutation is a reduction in the P2X4 receptor 
maximum response. The presence of an extra cysteine residue in the large ectodomain in 
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addition to the conserved 10 cysteines important for P2X receptor structure may permit aberrant 
disulphide bond formation leading to a disruption in ion channel structure. This hypothesis is 
supported by experiments using the Tyr315>Ser P2X4 receptor mutant which cannot form 
disulphide bonds and does not show a reduced maximum response, only a reduced agonist 
potency (Figure 2). In addition, experiments with the reducing agent DTT could rescue the 
reduction in 315Cys-P2X4 maximum response, apparently by rescuing non-functional receptors 
at the cell surface rather than by increasing cell surface expression. The simplest explanation of 
this data would be that aberrant disulphides involving 315Cys render some P2X4 receptors non-
functional but this is reversible with reduction by DTT.  
Genotyping of two groups of Caucasian subjects revealed that rs28360472 
(Tyr315>Cys) in P2RX4 was found in only 9 of 430 subjects in the Sydney cohort (minor allele 
frequency 0.011, Table 2) and in 90 of 2874 subjects in the Victorian cohort (minor allele 
frequency 0.014, Table 2). The loss-of-function polymorphism was predominantly found in 
heterozygous dosage therefore to mimic heterozygous inheritance of the Tyr315>Cys mutation 
we co-transfected HEK cells with a mixture of wild-type P2X4 and 315Cys-P2X4 receptor 
plasmids. This reduced the P2X4 response to 40% of wild-type suggesting that this functional 
defect would not be fully rescued by the presence of a wild-type P2X4 receptor allele. This 
reduction was also replicated in monocyte-derived macrophage from 315Cys-P2X4 
heterozygote subjects. 
Our previous studies have identified a modest but significant genetic contribution to 
pulse pressure in the Victorian Family Heart Study 25. Recent genetic analyses of population 
blood pressures have revealed the existence of common (population frequency >10 %) alleles of 
small effect (<1 mmHg) 26 and rare alleles (population frequencies < 0.1%) of modest effect (up 
to 6 mmHg) 27. The former are typically in non-coding regions of DNA while the latter are 
generally in amino acid coding sequences. Interestingly, rs28360472, encoding the Tyr315>Cys 
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amino acid mutation, falls somewhere between the common and rare alleles in terms of expected 
frequencies and estimated effect sizes.  
Pulse pressure represents the amplitude of the arterial pressure waveform and is 
recognised as a risk factor for cardiovascular disease, independent of systolic and diastolic blood 
pressures per se 28. Pulse pressure is determined by the compliance of large arteries, by the 
cardiac stroke volume and by reflected pressure waves. The P2X4 receptor has an important role 
in determining large vessel tone through endothelial-dependent mechanisms, such that P2X4 
receptor activation by ATP leads to endothelial cell NO release and arterial smooth muscle 
relaxation. Such reduced large arterial tone would increase vascular compliance and in the 
context of a dysfunctional 315Cys-P2X4 receptor, reduced endothelial NO release would favour 
decreased large arterial compliance and account for the higher pulse pressure seen in carriers of 
rs28360472.  
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Perspectives 
Many of the genetic correlates of blood pressure have focussed on renal mechanisms that 
control fluid and electrolyte balance. This study instead turns attention to vascular 
haemodynamic control mechanisms as defined by the actions of ATP that are mediated by the 
P2X4 receptor. The frequency of rs28360472 and the estimated magnitude of the inherited 
functional effect distinguish themselves from the often-reported common variants of small effect 
and the more rare mutations of moderate effect. These observations will stimulate further 
investigations into the role of ATP and P2X4 receptors in blood pressure and vascular 
homeostasis and a more detailed physiological study into the mechanisms by which pulse 
pressure and its underlying phenotypes might be altered by the dysfunctional 315Cys-P2X4 
receptor.  
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Figure Legends 
Figure 1: The Tyr315>Cys polymorphism in human P2X4 receptors shows a loss-of-
function effect. (A) Representative inward current traces for human P2X4 receptor 
expressed in HEK-293 cells in response to 10 µmol/L ATP applied for 5 seconds denoted 
by black solid bars. Inset: schematic diagram of a single P2X4 receptor subunit and 
location of four SNPs altering amino acids. (B) Concentration-response curve for wild-
type and mutant P2X4 receptors for ATP and (C) BzATP. Responses were normalised to 
cell capacitance and are plotted as mean current density (pA/pF) (n=3-8 cells per point). 
Due to the desensitising nature of P2X4 receptors, experiments were performed by 
applying a single concentration of ATP per cell. Key: Wild-type (closed black squares), 
Ala6>Ser (open white circles), Ile119>Val (closed black triangles), Ser242>Gly (open 
diamonds) and Tyr315>Cys (open inverted triangles). 
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Figure 2:  The Tyr315>Cys mutation disrupts P2X4 receptor ectodomain structure  
(A) Representative inward current traces for wild-type, 315Cys-P2X4 and 315Ser-P2X4 
receptors in response to 1 mmol/L ATP (black bars) and (B), concentration-response 
curves to ATP for wild-type (WT) (black closed squares), 315Cys-P2X4 (open white 
circles) and 315Ser-P2X4 (black closed triangles). (C) Representative inward current 
traces for wild-type (WT), and 315Cys-P2X4 compared to 315Cys-P2X4 receptor treated 
with 1 mmol/L DTT for 15 mins. (D) Responses to 1 mmol/L ATP from 3-4 cells are 
plotted as mean current density (pA/pF). 
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Figure 3: Heterozygosity for Tyr315>Cys P2X4 receptors. (A) Representative inward 
current traces for WT, Tyr315Cys-P2X4 and a 1:1 mixture of WT plus Tyr315Cys-P2X4 
receptor DNA transfected into HEK-293 cells. Responses to 10 µmol/L ATP applied for 
5 seconds are shown and are denoted by black bars. (B) Responses were normalised to 
cell capacitance and plotted as mean current density (pA/pF) (n=3-4 cells) ** P<0.01, * 
P<0.05 ANOVA. (C) Representative inward current traces to 100 µmol/L ATP applied 
for 5 seconds to macrophages from wild-type (n=3) or 315Cys heterozygote subjects 
(n=2). Responses were potentiated by 3 µmol/L ivermectin. (D) P2X4 responses were 
normalised to cell capacitance and plotted as mean current density (pA/pF) (n=13-15 
cells) ** P<0.01.  
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Figure 4: Molecular model of ATP-binding pocket in wild-type and 315Cys-P2X4 
receptors. The molecular model of human P2X4 receptors was built by homology to 
zebra-fish P2X4 receptor (pdb code 3I5D, (20)) with ATP computationally docked at the 
putative ligand-binding pocket. (A) Surface rendering of the overall structure of the 
trimeric receptor model colored by subunit, oriented with the membrane-inserted domain 
at the bottom of the picture with the membrane normal to the plane of the page. ATP can 
be seen docked at the putative binding site at the interface between the green and the blue 
subunits. (B) An enlargement of the ATP-binding pocket for the wild-type receptor with 
key residues labelled and coloured by atom type. Tyr315 is shown as spheres with C 
atoms coloured magenta. Docked ATP is shown as bonds, colored by atoms, with C 
atoms white. (C) The same view as for B for the 315Cys-P2X4 mutant receptor with the 
315Cys atom visible as a yellow surface patch. Docked ATP (with C atoms yellow) 
showed a different preferred docking pose relative to the wild-type P2X4 receptor. 
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Tables 
 
Mutation 
10 µM ATP  
Peak Amplitude  
(pA ± SE) 
% Desensitisation to  
10 µM ATP* 
 
ATP EC50 
µM)† 
BzATP EC50 
(µM)‡ 
Wild-type 111.1 ± 11.1 30.3 5.7 9.4 
Ala6>Ser 159.3 ± 30.3 29.2 2.3 nd 
Ile119>Val 101.3 ± 8.4 30.2 6.8 nd 
Ser242>Gly 135.1 ± 16.1 31.2 4.0 nd 
Tyr315>Cys 12.2 ± 2.3** 20.3* 198.7 71.8 
 
 
 
Table 1: Characterisation of four non-synonymous single nucleotide polymorphisms 
in the human P2X4 receptor. 
 
*Desensitisation was measured as percentage decline over 4 seconds from the peak of the 
inward current as described in (8). †EC50 value for ATP was determined from 
concentration-response curves generated from application of a single concentration of 
ATP per cell to eliminate any effect of desensitisation. ‡EC50 value for BzATP was 
determined from concentration-response curves generated from application of a single 
concentration of BzATP per cell to eliminate any effect of desensitisation. nd = not 
determined. ** P<0.01, * P<0.05.  
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dbSNP id Amino acid change Minor Allele frequency Number of subjects 
rs1044249 Ala6>Ser 0 200* 
rs28360470 Ile119>Val 0 200* 
rs25644 Ser242>Gly 0.116 268* 
rs28360472 Tyr315>Cys 0.011 430* 
    
rs28360472 Tyr315>Cys 0.014 2874† 
 
 
 
Table 2: Frequencies of four non-synonymous SNPs in P2RX4.  
 
 
*Subjects were recruited from the greater Sydney area for genotyping. 
†Subjects were part of the Victorian Family Heart Study   
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Variable rs28360472 
A/A (n=2784) 
rs28360472 
A/G or G/G (n=90) 
Age (years) 39.8 ± 15.8 36.68 ± 15.69 
Weight (kg) 71.7 ± 14.0 72.57 ± 13.02 
Height (mm) 1690 ± 93 1706.3 ± 89.0 
   
Systolic BP (SBP) 123.3 ± 15.4 124.8 ± 15.1 
   
Diastolic BP (DBP) 72.6 ± 11.6 71.3 ± 11.6 
   
   
Pulse Pressure (PP) 50.7 ± 12.0 53.5 ± 12.5* 
   
   
   
 
 
Table 3: Blood pressure measurements correlated with P2RX4 genotype at rs28360472 for 
2874 subjects from the Victorian Family Heart Study.  
 
* represents P<0.05 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
